Seeking Alpha

Shares of Alexion Pharamaceuticals (ALXN +3.4%) register a gain after the firm says it has...

Shares of Alexion Pharamaceuticals (ALXN +3.4%) register a gain after the firm says it has received a positive opinion in Europe for Soliris with a final decision from the European Commission expected in about two months. Soliris is a first treatment for patients with a rare life-threatening blood disorder.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs